Contract 75A50325C00002
Accord Biopharma, Inc. · Department Of Health And Human Services · March 6, 2026
Accord Biopharma, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on March 6, 2026 for $7.62 million of work in pharmaceutical preparation manufacturing. Performance is in Redwood City, CA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2026. If all options are exercised, the contract could reach $45.16 million.
Contract details
- PIID
- 75A50325C00002
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Redwood City, CA
- First action
- March 6, 2026
- Latest action
- March 18, 2026
Description
EXERCISE ORDERING PERIOD 1
Modification timeline
-
March 18, 2026Mod P00002 · Novation Agreement$19.42M
-
March 6, 2026Mod P00001 · Novation AgreementNOVATION AND CHANGE-OF-NAME AGREEMENT$11.81M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50325C00002?
Contract 75A50325C00002 is a federal contract awarded to Accord Biopharma, Inc. by Department Of Health And Human Services on March 6, 2026 for $7.62 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75A50325C00002?
Accord Biopharma, Inc. won contract 75A50325C00002 from Department Of Health And Human Services.
How much is contract 75A50325C00002 worth?
Contract 75A50325C00002 has obligated $7.62 million to date, with a total potential value of $45.16 million if all options are exercised.